You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,069,851


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,069,851
Title:Aeorosolization apparatus with air inlet shield
Abstract: An aerosolization apparatus comprises a housing defining a chamber having a plurality of air inlets. The chamber contains an aerosolizable pharmaceutical formulation or is sized to receive a receptacle which contains an aerosolizable pharmaceutical formulation. A shield covers at least one of the air inlets or a portion of at least one of the air inlets. The shield prevents blockage of the air inlet by a user grasping the apparatus and inadvertently covering the air inlet. An end section is associated with the housing. The end section is sized and shaped to be received in a user's mouth or nose so that the user may inhale through the end section to inhale aerosolized pharmaceutical formulation that has exited the receptacle.
Inventor(s): Dunkley; Michael John (Nottingham, GB), Tuckwell; Jon David (Cambridgeshire, GB), Vernon-Harcourt; Edward William (Cambridge, GB), Shirgoankar; Sameer (London, GB)
Assignee: Novartis AG (Basel, CH)
Application Number:12/456,807
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,069,851: A Detailed Analysis

Introduction

United States Patent 8,069,851, titled "Aerosolization Apparatus with Air Inlet Shield," is a patent that protects an innovative design in the field of pharmaceutical delivery systems. To fully comprehend the patent's implications and its place in the patent landscape, it is crucial to delve into its scope, claims, and the broader context of patent law and practice.

Patent Overview

Invention Description

The patent describes an aerosolization apparatus designed for delivering aerosolizable pharmaceuticals. The apparatus includes a housing that defines a chamber with multiple air inlets, an aerosolizable pharmaceutical contained within the chamber, and an air inlet shield to regulate airflow and improve the efficiency of aerosolization[4].

Scope of the Patent

Claims Analysis

The patent's scope is primarily defined by its claims, which outline the specific elements and limitations of the invention. Here are some key aspects of the claims:

Independent Claims

Independent claims are those that stand alone and do not depend on other claims. For US Patent 8,069,851, these claims typically describe the overall structure and function of the aerosolization apparatus, including the housing, chamber, air inlets, and air inlet shield.

Dependent Claims

Dependent claims build upon the independent claims and add additional limitations or features. These claims might specify particular materials, dimensions, or operational parameters of the apparatus.

Claim Language and Scope

The language used in the claims is critical for determining the patent's scope. For example, if a claim specifies that the air inlet shield is "adjustable," this could limit the scope to only those embodiments where the shield can be adjusted. Conversely, broader language might encompass a wider range of variations, potentially increasing the patent's scope[3].

Patent Eligibility and Subject Matter

Abstract Ideas and Practical Applications

Recent updates in patent law, such as the 2024 USPTO guidance on AI patents, emphasize the importance of integrating abstract ideas into practical applications to ensure patent eligibility. While US Patent 8,069,851 does not involve AI, the principle remains relevant. The patent's claims must demonstrate a concrete technological improvement and a practical application, such as enhancing the efficiency of aerosolization, to be considered patent-eligible[1].

Inventorship and Contribution

Determining True and Only Inventors

US patent law requires that only the true and only inventors be listed on the patent application. This involves identifying those who conceived the idea and reduced it to practice. For US Patent 8,069,851, the inventors listed would have played a significant role in both the conception and the practical implementation of the aerosolization apparatus[2].

Patent Prosecution and Examination

Process and Challenges

The patent prosecution process for US Patent 8,069,851 would have involved several steps, including filing a provisional or non-provisional patent application, responding to office actions from the USPTO, and potentially appealing any rejections. The process can be lengthy, often taking two to five years, and may require amendments to the claims to overcome rejections[5].

Costs and Commercial Considerations

The costs associated with patenting, including drafting, filing, and prosecuting the patent, can be substantial. For US Patent 8,069,851, these costs would have included fees for drafting the application, responding to office actions, and any appeals. Commercial partners may sometimes cover these costs, especially if there is a clear commercial value to the invention[5].

Real-World Applications and Benefits

Improving Pharmaceutical Delivery

The aerosolization apparatus protected by US Patent 8,069,851 is designed to improve the delivery of aerosolizable pharmaceuticals. By regulating airflow and enhancing the efficiency of aerosolization, the apparatus can provide better treatment outcomes for patients. This practical application is a key factor in its patent eligibility and commercial value.

Integration with Recent Case Law and Guidance

Applying Recent Legal Standards

The 2024 USPTO guidance on AI patents, while not directly applicable to this mechanical invention, highlights the importance of integrating judicial exceptions into practical applications. Similarly, for US Patent 8,069,851, the claims must reflect a tangible improvement in technology, such as improved aerosolization efficiency, to align with current legal standards[1].

Key Takeaways

  • Claims Analysis: The scope of the patent is defined by its claims, which must be carefully drafted to ensure they cover the invention without being overly broad or too narrow.
  • Practical Applications: The invention must integrate abstract ideas into practical applications to be patent-eligible.
  • Inventorship: Only the true and only inventors should be listed on the patent application.
  • Patent Prosecution: The process involves filing, responding to office actions, and potentially appealing rejections.
  • Commercial Value: The costs of patenting can be significant, but commercial partners may cover these costs if the invention has clear commercial value.

FAQs

Q: What is the main innovation protected by US Patent 8,069,851?

A: The main innovation is an aerosolization apparatus with an air inlet shield designed to improve the efficiency of aerosolizing pharmaceuticals.

Q: How long does the patent prosecution process typically take?

A: The patent prosecution process can take two to five years, depending on the complexity of the invention and the responses required from the USPTO.

Q: What are the key factors in determining patent eligibility for mechanical inventions like US Patent 8,069,851?

A: The key factors include integrating the invention into a practical application, demonstrating a concrete technological improvement, and ensuring the claims are not overly broad or too narrow.

Q: Who should be listed as inventors on a patent application?

A: Only the true and only inventors who conceived the idea and reduced it to practice should be listed.

Q: What are the potential costs associated with patenting an invention like US Patent 8,069,851?

A: The costs can range from $8,000 to $20,000 for a U.S. non-provisional patent application, with additional costs for international patents and patent prosecution.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims and Patent Scope - SSRN
  4. US8069851B2 - Aerosolization Apparatus with Air Inlet Shield - Google Patents
  5. Intellectual Property Protection - KU Office of Research

More… ↓

⤷  Subscribe


Recent additions to Drugs Protected by US Patent 8,069,851

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 8,069,851

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,069,851

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 549051 ⤷  Subscribe
Australia 2004229446 ⤷  Subscribe
Canada 2520032 ⤷  Subscribe
Cyprus 1113859 ⤷  Subscribe
Denmark 1610850 ⤷  Subscribe
European Patent Office 1610850 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.